LipimetiX Development, Inc.

New Filing
CIK: 0001683387·Pharmaceuticals·DELAWARE·Filed: Sep 8, 2016
Total Offering

Indefinite

Amount Sold

$1,011,606

Investors

12

First Sale

Aug 25, 2016

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2012
Non-Accredited Investors
No

Related Persons

NameRole
DENNIS I GOLDBERG, PH.D.
Related Person
ERIC M MORREL, PH.D.
Related Person
PHILLIP M FRIDEN, PH.D.
Related Person
JOHN M HOLLIMAN, III
Related Person
RANDOLPH C STEER, M.D., PH.D.
Related Person

Company

LipimetiX Development, Inc.

5 COMMONWEALTH ROAD

NATICK, ME, 01760

602-286-5520

SEC Filing

0001683387-16-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
LipimetiX Development, Inc. Form D Filing — Indefinite | FilingFlow